Split hand/split foot malformation (SHFM) is a heterogeneous limb developmental disorder, characterized by missing digits and fusion of remaining digits. An autosomal dominant form of this disorder (SHFM1) has been mapped to 7q21.3-q22.1 on the basis of SHFM-associated chromosomal rearrangements. Utilizing a YAC contig across this region, we have defined a critical interval of 1.5 Mb by the analysis of six interstitial deletion patients and mapped the translocation breakpoints of seven ectrodactyly patients within the interval. To delineate the basic molecular defect underlying SHFM, we have searched for candidate genes in a 500 kb region containing five of the translocation breakpoints. Three genes were identified, two genes of the Distal-less (dll) homeobox gene family, DLX5 and DLX6 and a novel gene, which we named DSS1. DSS1 is predicted to encode a highly acidic polypeptide with no significant similarity to any known proteins but 100% amino acid sequence identity with its murine homolog (Dss1). Using RNA in situ hybridization analysis, we detected a tissue-specific expression profile for Dss1 in limb bud, craniofacial primordia and skin. A deficiency in expression of DSS1, DLX5 and/or DLX6 during development may explain the SHFM phenotypes.
INTRODUCTION
Split hand/split foot malformation (SHFM) is a form of ectrodactyly, characterized by deep median clefts, missing digits and a claw-like appearance of the distal extremities consistent with a developmental defect of the growth and patterning of the central digital rays (1) . SHFM is clinically heterogeneous (2) , presenting in both an isolated form and in combination with additional anomalies affecting the long bones (non-syndromic ectrodactyly) and/or other organ systems including the craniofacial, genitourinary and ectodermal structures (syndromic ectrodactyly or SE) (3) . The most notable example of syndromic ectrodactyly is the EEC (ectrodactyly, ectodermal dysplasia and cleft-lip/palate) syndrome (4) .
Although most SHFM cases occur sporadically, familial forms have been observed with the majority showing autosomal dominant inheritance (3), while some autosomal recessive (5, 6) and X-linked (7) patterns of inheritance have been reported. Peculiar patterns of transmission have been reported for >60% of SHFM pedigrees, in which about 30% of obligate carriers show no phenotypic abnormalities (1) . In addition, variable expressivity is a hallmark of both syndromic and non-syndromic SHFM. Remarkably different phenotypes, ranging from mild abnormalities of a single limb to severe defects of all four limbs, may be observed. Moreover, segregation distortion with excessive transmission of SHFM from affected fathers to sons has been detected in some pedigrees (8, 9) . *To whom correspondence should be addressed + These authors contributed equally to this work A subset of SHFM and SE patients were found to have cytogenetically visible chromosome rearrangements. Molecular studies of these patients have led to the assignment of an autosomal dominant form of the disease to 7q21.3-q22.1 (10, 11) ; the locus has been designated SHFM1 (McKusick #183600). A physical map consisting of overlapping yeast artificial chromosome (YAC) clones encompassing this entire region has been constructed (12) . Together with the mapping of deletion breakpoints, a critical region of ∼1.5 Mb could be established for the SHFM1 locus (12) . Further, the breakpoints for six patients with translocation (or inversion) were localized within the critical region. Although these patients included both simple SHFM and complex SE, there was no obvious correlation between the sites of chromosomal disruption and clinical severity.
Haploinsufficiency may be considered the cause of SHFM1 (12) . Deletion, translocation or inversion involving the critical region may affect the activity of one or a series of genes, through either direct interruption of the gene(s) or their regulatory elements. To gain further insight into the molecular basis underlying SHFM1, we have initiated a systematic search for candidate genes located in the critical region. Our emphasis has been concentrated on a 500 kb region that spans five of the seven known translocation breakpoints. In this report, we describe the identification of three genes in this region. Two of them belong to the Drosophila distal-less (dll) homeobox gene family, DLX5 and DLX6 (13) , which have been previously implicated in limb development (13) (14) (15) . Here we provide a detailed characterization of the third gene which has not been previously described. We also present RNA in situ hybridization data to show its expression profile during mouse limb, craniofacial and skin development. All available data suggest that this gene is a strong candidate that should be considered when delineating the etiology of SHFM and SE.
RESULTS

The minimal critical region for SHFM1
In an attempt to delimit the critical region of the SHFM1 locus, we characterized four additional patients, namely, D6, D7, T6 and T8, with chromosome 7 abnormalities by FISH, somatic cell hybrid, densitometry, or microsatellite analysis, using the physical mapping reagents shown in Figure 1 . The clinical and cytogenetic description of all patients except D7 has been described (D6 in ref. 16 ; T6 in refs 12 and 17; T8 in ref. 18) . D7 corresponded to an EEC patient with an interstitial deletion of 7q21.3 detectable by molecular analysis only. The deletion breakpoints of this patient were found to lie just outside of the region shown in Figure 1 , which confirmed the critical genetic region for SHFM1 but failed to narrow the position for the disease locus. The proximal deletion breakpoint of patient D6 has, however, allowed us to refine the critical interval to about 1000 kb. In addition, all seven translocation breakpoints could be mapped within a 700 kb region and five of them (T1, T2.2, T4, T5 and T6) within 500 kb of each other (see Fig. 1 ). As the latter breakpoint cluster was found to be encompassed by two overlapping YAC clones (HSC7E571 and HSC7E1131), it was reasonable to focus our initial gene identification study on these clones.
Identification of genes in the SHFM1 critical region
Direct cDNA selection, detection of evolutionarily conserved sequences and exon amplification were used to isolate putative transcribed sequences from genomic clones covering the critical region. In this paper we present the results from this search for the region encompassed by both HSC7E571 and HSC7E1131 ( Fig.  1 ) (the clones isolated from HSC7E1170 and HSC7E1301 will be described elsewhere). A total of 97 cDNA fragments, 20 conserved DNA segments and 15 putative exons were characterized. These clones were sequenced, grouped and aligned, analyzed by northern blot with RNA from various tissues, examined for their correspondence to genomic DNA segments that showed sequence conservation with other species and used as probes to screen cDNA libraries. In addition, the cDNA sequences were used to search all available public databases for identity and homology and for coding and splicing potential. From this exhaustive analysis, so far, only three 'bona fide' transcription units could be discerned (Fig. 1) . The transcription orientation of these genes were determined by fine restriction enzyme mapping and blot hybridization analysis with different cDNA segments as probes (data not shown).
Two of the genes, DLX5 and DLX6, were reported previously (12, 13) . The 5′ end of DLX6 could not be determined because it was not represented in any of the selected cDNA clones nor recovered from cDNA libraries made in the conventional manner. The third gene was not previously described and was thus assigned the gene symbol DSS1 (for deleted in the split hand/split foot SHFM1 region). As shown in Figure 1 , DSS1 was mapped towards the proximal end of YAC clone HSC7E571 and the gene appeared to be surrounded but not directly interrupted by any of the four rearrangement breakpoints mapped nearby. The closest breakpoint, T6, was localized within 10 kb of the 3′-end of the gene while three others, T4, T2.2 and T5, are on either side, within 100 kb (Fig. 1) . It should be noted that T2.2 belonged to a simple SHFM patient and that the other three, to complex SE patients.
Characterization of DSS1 and its murine homolog (Dss1)
Based on the combined sequences of the various overlapping clones and two apparent full-length clones, a consensus cDNA of 494 bp could be established for DSS1 (Fig. 2) . A putative open reading frame encoding for 70 amino acids was identified with the first available methionine codon being the initiation codon, which appeared to conform well to the Kozak consensus sequence (19) . A polyadenylation signal (AATAAA) was found 11 bp upstream of the poly(A) tail. The deduced DSS1 polypeptide appeared to be highly acidic with 27 residues being either aspartic or glutamic acids (∼40%). Database searches failed to detect any significant identity with known proteins or protein motifs, but a portion of the DSS1 DNA sequence was found in the dbEST database.
Northern blot analysis revealed a single RNA species of about 500 nt in size as the DSS1 mRNA, which was present at low levels in all the adult and fetal tissues examined, although the level appeared to be the lowest in adult brain (Fig. 3a) . The transcriptional start site was determined using the 5′-RACE method (20) . Total RNA was isolated from both fibroblast and Caco-2 (a colon carcinoma cell line) and used as template for the 5′ extension reaction (DSS1 was known to be expressed in these cells). The extension product appeared as a discrete band on the agarose gel (Fig. 3b) . The band was excised and cloned. The DNA sequences were determined for 14 independent clones and the result indicated that the position for the major transcriptional start site was located at 104 bp upstream from the putative initiation codon (Fig. 3c ). This result was also consistent with the A composite of the location of the rare-cutter restriction enzymes determined by PFGE-mapping the YACs is also shown. The breakpoints contained in T1, T2.2, T4, T5 and T6 were localized within the DNA segments defined by phage P.1-13, cosmids 47e9, 64b4, 191f10 and 177c8, respectively. The location and relative orientation (the arrow denotes the 5′-3′ direction) along the chromosome, of DSS1, DLX6 and DLX5, is shown. The immediate region around each gene is magnified below to show the local restriction map and the exact position of the three exons of DSS1. The dashed line for DLX6 denotes that the 5′-end of the gene has not been identified. The origin of the genomic clones used to derive the local restriction map was: those with names preceded by a P-or S-were from a phage library constructed from HSC7E571 (12) or total human genomic DNA, respectively; all others were cosmids from a chromosome 7-specific library (Lawrence Livermore National Laboratory). Examples of DNA segments that demonstrated excellent cross-species conservation (but apparently do not encode genes) are shown. The method of isolation and source of these clones is reflected in the nomenclature (those preceded by their source YAC address and 'cd' were isolated by direct cDNA selection, the rest were subclones of the phage carried in their name). The gap between the contigs is bridged by cosmid and PAC clones (data not shown). B = BssHII,
presence of a few minor transcriptional start sites, as observed for most TATA-less promoters (21) .
Restriction mapping analysis showed that DSS1 consisted of three exons spanning approximately 20 kb of genomic DNA and that the gene was oriented with its 3′-end centromeric to the 5′-end (Fig. 1) . The genomic DNA regions that were detected by blot hybridization analysis were also sequenced. The DNA sequences at the intronexon boundaries (Fig. 2 ) all appeared to conform to the canonical splice donor and acceptor sequences (22) . There was also no apparent TATA box upstream of the major transcription start site (Fig. 3c) .
To prepare for RNA in situ hybridization analysis in the developing mice, the corresponding mouse gene, Dss1, was isolated by screening a limb bud cDNA library with the human gene. Five apparently full-length mouse cDNA clones were isolated and the DNA sequence of the coding region was found to be 90% identical to the human, differing only at the wobble positions (Fig. 2) . The absolute conservation between the human and mouse genes at the amino acid level suggested critical importance of the entire polypeptide at the functional level. Hybridization signals were also detected in several other species (Fig. 2b) , suggesting the existence of DSS1 homologs and functional conservation during evolution.
Expression of Dss1 during development
To investigate the function of DSS1 and its relationship with SHFM and SE, we examined the expression pattern of the gene using RNA in situ hybridization with whole mounts and sections of developing mouse embryos and newborn animals. For these studies, the murine cDNA clone, including the 3′-untranslated region, was used to generate sense and anti-sense riboprobes. As revealed by the results of whole mount studies shown in Figure 4 , expression of Dss1 could be detected at various stages of embryonic development. At embryonic day 9.5 (E9.5), Dss1 was found to express strongly in the mesenchyme of the first branchial arch and the frontonasal prominence (Fig. 4a) . As facial development progressed, the expression was laterally restricted in the maxillary and mandibulary prominence of the first and second branchial arch (data not shown), consistent with a role in the development of the bones of the lower face and jaw. By E12.0 the expression appeared to be restricted to the region of the prospective tooth buds (data not shown). In addition to the facial primordium, expression of Dss1 was detected in the early genital tubercle, but it was not followed after E12.5 (data not shown). The results of embryo and newborn section analysis also revealed that the expression of Dss1 was widespread at low levels (data not shown), thus in good agreement with the northern blot results. In addition, Dss1 was found to be strongly expressed in the dermis of new born mice (Fig. 4b-d) . The latter expression pattern seemed relevant to the ectodermal dysplasia phenotype in the syndromic ectrodactyly patients.
Localized Dss1 expression in developing limbs
The spatial and temporal pattern of expression of Dss1 was examined in the developing mouse limb bud by using whole mount RNA in situ hybridization (Fig. 5) . At E9.5, when the first signs of limb bud outgrowth were evident (23), Dss1 expression could be detected ubiquitously throughout the mesenchyme of the structure but not in the ectoderm (data not shown). As the limb bud elongated, Dss1 was no longer expressed in the proximal mesenchyme. At E11.0, in the fore limb bud, expression was only apparent in the distal mesenchyme and the peripheral regions of the medial mesenchyme (Fig. 3a) . It was presumed that, at this stage, the mesenchymal cells of the central core of the limb bud were condensing to form the stylopodial or zeugopodial elements (23) . In E12.5 embryos, Dss1 expression in the fore limb was found to be further restricted as the mesenchymal condensations occurred in the initial stages of digit formation (Fig. 3b) . At this stage, the Dss1 gene appeared active in the interdigital mesenchyme, but not in the condensing mesenchyme.
As limb development proceeded, the expression of Dss1 in the core of the interdigital mesenchyme dissipated in a proximodistal direction and it became restricted to the mesenchyme just outside the perichondrium of the developing digits by E13.25 ( Fig. 3c) . At this stage in the hind limbs the border of the staining was more proximal than in the fore limbs observed. This difference may be a transient change in expression pattern seen in both the fore and hind limb, or it may be hind limb specific. It may also be just experimental variation. Additional studies will need to be carried out to resolve this uncertainty. Finally, while the digital condensations were undergoing segmentation during the formation of phalanges (at E13.5), Dss1 outlined the pattern of the prospective bones (Fig. 3d) . Therefore, the Dss1 expression pattern, which was similar, if not identical, in the fore-and hind-limb buds with respect to their relative stage of development, was consistent with that of a gene with a role in the early specification of digit formation (24) .
DISCUSSION
Through the molecular characterization of the genomic rearrangements found in a group of patients with SHFM and SE, we have identified a novel gene that appears to play an important part in limb, craniofacial, skin and genitourinary development. The gene, DSS1, which encodes a highly conserved and acidic protein, maps within the critical region and is closely surrounded, but not directly interrupted, by the chromosomal translocation breakpoints found in the patients. Based on RNA in situ hybridization analysis with the murine homolog, Dss1, the gene appears to express predominantly in the limb and facial primordia during days 9.5-13.5 of mouse development. It is also expressed strongly in the dermis of newborn mice, the early genital bud and possibly the tooth primordium. Thus, a reduction in the expression of this gene during human embryogenesis may not only explain the phenotype observed in SHFM1 patients, but also some forms of syndromic ectrodactyly including EEC. A number of previous studies in mouse (13) , rat (14) and chick (15) indicate that Dlx5 and Dlx6 are expressed during development in a unique spatial and temporal pattern. The expression pattern of the mouse Dlx5 and Dlx6 genes are almost identical (13) . Both show strong signals in facial and branchial arch mesenchyme, otic vesicles and frontal ectoderm around olfactory placodes at E8.5-9 and in the developing forebrain in primordia of the ganglionic eminence and ventral diencephalic regions at E10. At midgestation (E12.5), they are expressed in almost every developing skeletal element and in the forebrain. Expression of Dlx5 can also be detected in regions of ossification, as well as ear ossicles and primordia of teeth. In the rat, the expression pattern has only been studied with Dlx5 and the pattern is essentially the same as that of the mouse, but showing an additional site in epidermis of the skin and the apical ectodermal ridge (AER) of limb buds (14) . The study of Dlx5 in chick is primarily focused on limb development and the description of its expression pattern is more refined (15) . In addition to AER, the expression of the chick Dlx5 gene is found in the mesoderm at the anterior margin of the limb bud and in a discrete group of mesodermal cells at the mid-proximal posterior margin that correspond to the posterior necrotic zone.
The human DLX5 and DLX6 were previously localized to the 7q22 region by fluorescence in situ hybridization (13) . Their possible involvement in SHFM was also suggested (13). Our previous physical mapping studies placed these two genes in the SHFM1 critical interval, thus providing further support to this assumption. Based on the RNA in situ hybridization data, DLX5 and DLX6 are equally strong candidates as DSS1 in explaining the SHFM and SE phenotypes. It is of importance to note, however, that no mutation could be detected in these genes in sporadic SHFM patients (25) . Moreover, although DLX5 and DLX6 are located within the critical interval defined by the deletion breakpoints, they are not interrupted by the translocation breakpoints. If reduced expression of the two genes is part of the etiology of SHFM and SE, they must be regulated by distantly located control elements which become separated in the translocations (see below). The same argument would apply to DSS1.
We have also designed oligonucleotide primers flanking the exons of DSS1 (Fig. 2) to facilitate the search for mutations in SHFM patients. All three exons have been scanned in 60 sporadic SHFM1 patients but, so far, no mutation could be detected (J. Evans and P. Charlton, unpublished data). In fact, previous studies showed that polymorphic markers located within the SHFM1-critical region failed to demonstrate linkage to the phenotype in several large SHFM families (26) (27) (28) (29) . At least one additional adSHFM locus (named SHFM3) has been recently mapped on chromosome 10q (29) . Genetic heterogeneity has also been suggested on the basis of different clinical subtypes of non-syndromic SHFM (30) . It is probable that the SHFM and SE phenotypes are caused only by deletion or translocation affecting the SHFM1 locus. Therefore, searching for point mutations in DSS1, DLX5 and DLX6 may not be an effective strategy to demonstrate the role of these genes in limb development.
To explain how deletions and translocations at the SHFM1 locus could cause the SHFM phenotype, we have offered three different possibilities (12) . We have first suggested there could be a large gene that was disrupted by all the translocations found in the patients. This explanation requires the presence of a gene of at least 700 kb in size, spanning most, if not all, of the translocation breakpoints. Despite exhaustive searching, we have not identified such a gene in the region. We have also suggested the presence of a number of genes in this region essential for limb development and that disruption of expression of any of them could lead to the observed phenotype. While this hypothesis is supported by the identification of three genes that share very similar expression patterns, none of them are directly interrupted by any of the translocation breakpoints nor have point mutations been detected in any of the sporadic patients. The third hypothesis that appears attractive is based on the notion of gene regulation by distant cis-acting regulatory elements, or long range position effects. Removal of these elements from DSS1, DLX5, DLX6, or other genes yet to be identified in this region may result in aberrant gene expression leading to the abnormal development.
The expression of DSS1 may be particularly susceptible to the proposed position effect because the gene is closely surrounded by the translocation breakpoints which do not interrupt any other known genes in the region. Other examples of genes for which a position effect has been proposed include SOX9 for campomelic dysplasia (31) , PAX6 for aniridia (32) , GLI3 for Greig's cephalopolysyndactyly (GCPS) (33), the Steel-locus for ovarian follicle development (34) , the agouti coat color gene (35) , POU3F4 for familial X-linked deafness (36) and myosin VI for Snell's waltzer deafness (37) . For some of these genes, expression is affected by rearrangements 50-400 kb away. Therefore, the expression of DSS1, DLX5 and DLX6 may all be affected by the deletions as well as the translocations described for the SHFM and SE patients. The similar spatial and temporal expression pattern detected for these genes during development is in good agreement with this assumption. As there is no correlation between the extent of deletion or the location of translocation and the clinical phenotypes in SHFM and SE, the observed variable expressivity and penetrance are probably due to other genetic factors. All these hypotheses may be tested by the generation of mice with specific gene disruptions through homologous recombination (38) .
A spontaneous mouse mutant, dactylaplasia (Dac), with a phenotype closely resembling that of SHFM in humans has been described (39) . The expression of the abnormal Dac phenotype is dependent on homozygosity for a recessive allele of another unlinked gene named mdac. Dac and mdac represent the only characterized two-locus system for a naturally occurring congenital malformation (40) . Dac maps near Pax2 on mouse chromosome 19 (40) and based on syntenic relationships this is the same general region in human (10q23-q25) to which SHFM3 has been mapped (29) . The mdac locus maps to mouse chromosome 13 which has regions of synteny on human chromosome 5q and 9q (41) . While Dac may be a model for SHFM3, neither it or mdac share synteny to human chromosome 7q, so it is unlikely that they are involved in SHFM1. A two-locus model similar to Dac-mdac in humans might, however, explain some of the unusual features of inheritance observed in SHFM including the irregular forms of transmission, reduced penetrance and disturbed segregation ratios.
Finally, while DLX5 and DLX6, as members of the Distal-less family, may serve as transcription regulators that control the expression of other genes that are required for limb, craniofacial and skin development, it is difficult to predict the biological function for DSS1. However, the expression pattern of Dss1 during limb development is similar to that of Gli3 which may provide insight into its function. Gli3 encodes a zinc finger protein whose reduced expression is known to cause extra-toes in mouse (42) and GCPS in humans (33) . GLI3 is thought to play a part in programmed cell death as its disruption results in an increase in the number of digits and the lack of digital separation. Similarly, the SHFM1 phenotype may be due to a loss of the overall control of programmed cell death in which an increase could result in the loss of digits and a decrease could result in the fusion of digits. Alternatively, it may be proposed that DSS1 is required to maintain cells in an undifferentiated state or that it promotes the proliferation of these cells. In support of this assumption, DSS1 expression is present in regions of rapid cell growth (limb bud, branchial arch, genital bud, skin) and excluded from regions of cell differentiation (e.g. digital condensations). In addition, DSS1 expression is widespread early in the developing embryo (not shown) and as development progresses and the fate of cell lineages become determined Dss1 expression dissipates and is found in late developing tissues that remain in an undifferentiated state. Although further studies are required to delineate the biological function(s) of DSS1 and those of DLX5 and DLX6, they are excellent candidates for study of limb development.
MATERIALS AND METHODS
FISH mapping of chromosome rearrangements in SHFM and SE patients
The precise breakpoints of rearrangements determined by FISH were localized within the cloned genomic DNA segments on the basis of altered signal intensity (as in the case of chromosome deletion) and splitting signals (for translocation), as described (12) .
Gene identification
Direct cDNA selection was performed with YAC clones HSC7E571 (12) and HSC7E1131 (12) according to described methodology (43) . Briefly, the YAC DNA was purified away from the endogenous yeast chromosomes by pulsed field gel electrophoresis, transferred to nylon membrane and used as substrate for exhaustive hybridization with PCR-amplified cDNA pools made from RNA isolated from 10 tissues (43). Exon amplification was conducted on 'tiling path' phage and cosmid clones shown in Figure 1 using the pSPL3 vector and the protocols described by the supplier (Gibco/BRL). To identify evolutionarily conserved DNA sequences genomic subclones from the phage, cosmid and YACs were hybridized systemati-cally against DNA from seven different species (shown in Fig. 2) . The 132 DNA segments retrieved in these experiments that mapped back to the expected genomic clones were analyzed by DNA sequencing, northern blot analysis with RNA from various tissues as indicated and Southern blot analysis with genomic DNA (cloned and uncloned) according to standard protocols (44) . The DNA sequences were grouped and aligned, if overlapping, examined for potential open-reading frames and used to screen GenBank, dbEST and other databases for sequence identity and possible motifs.
cDNA clones and libraries
FC3 was a 1.5 kb full-length DLX5 cDNA isolated from a human frontal cortex library (Stratagene) with one of the selected clones. Similarly, one DLX6-specific clone (FB325) was isolated from a human fetal brain cDNA library (Stratagene). The latter cDNA (1.4 kb) was determined to be less than full length on the basis of the size of the mRNA (2.5 kb) and the result of DNA sequencing. The full-length DSS1 clones FC4C and FB41A were isolated from cDNA libraries of the frontal cortex and fetal brain, respectively. Five full-length Dss1 mouse clones were isolated from an oligo dT-primed cDNA library constructed in the λZAP vector (Stratagene) with mRNA pools of the limb buds from E9.5 to E13.0 mouse embryos.
Gene structure analysis
Human genomic DNA fragments hybridizing to the cDNA clones were isolated and cloned into pBluescript™ (Stratagene) for sequencing analysis. The exon-intron boundaries were identified by sequence alignment. The transcription initiation sites for DSS1 were determined by the use of the 5′-RACE (rapid amplification of cDNA ends) kit (Life Technologies). Caco-2 and fibroblast total cellular RNA was reverse transcribed with an anti-sense oligonucleotide primer (5′-TATGAAGTCTCCATCTTAT-3′). The first round PCR was performed in a total volume of 50 µl for 35 cycles with the primer annealing at 50_C, followed by a 'nested-PCR' with gene specific primer (5′-TCTCTAGTT-CAGCTCGTAAC-3′). PCR products were subcloned into the pCRII™ TA cloning vector (Invitrogen).
RNA in situ hybridization
Mouse (CD1 strain) embryos were used in this study. Staging of the developing embryos was determined in reference to the first midday when vaginal plug was detected as E0.5. Whole-mount in situ hybridization using a digoxigenin-labeled RNA probe and an alkaline phosphatase-coupled anti-digoxigenin antibody was performed as described (45) . Paraffin sections of developmentally staged embryos were hybridized with 35 Slabeled sense and anti-sense probes as described previously (42) . Adjacent sections were examined to allow accurate localization of expression patterns.
ABBREVIATIONS
AER, apical ectodermal ridge; cDNA, complementary DNA; DNA, deoxyribonucleic acid; DSS1, human 'deleted in split hand/split foot malformation' gene 1; dss1, mouse DSS1 homolog (ortholog); E, embryonic day; EEC, ectrodactyly, ectodermal dysplasia, cleft lip/palate syndrome; FISH, fluorescence in situ hybridization; GCPS, Greig's cephalopolysyndactyly; PCR, polymerase chain reaction; RNA, ribonucleic acid; 5′RACE, 5′ rapid amplification of cDNA ends; SE, syndromic ectrodactyly; SHFM, split hand/split foot malformation; SHFM1, split hand/split foot malformation locus 1 (chromosome 7); YAC, yeast artificial chromosome.
